Loading clinical trials...
Loading clinical trials...
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain
Conditions
Interventions
LY3016859 ISA
LY3556050 ISA
+4 more
Locations
64
United States
Central Research Associates
Birmingham, Alabama, United States
Simon Williamson Clinic
Birmingham, Alabama, United States
Synexus Clinical Research - Glendale
Glendale, Arizona, United States
Synexus Clinical Research US, Inc.
Phoenix, Arizona, United States
Arizona Research Center
Phoenix, Arizona, United States
Alliance for Multispecialty Research, LLC
Tempe, Arizona, United States
Start Date
January 30, 2020
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2027
Last Updated
April 20, 2026
NCT06234631
NCT06169488
NCT05508360
NCT06825390
NCT07364578
NCT06488144
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
1-317-615-4559LillyTrials@Lilly.comPhysicians interested in becoming principal investigators please contact
CONTACT
clinical_inquiry_hub@lilly.comLead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions